• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
RAK
Click for more information
2.94% 66.0¢

Rakon Limited Ordinary Shares

watchlist Created with Sketch. Add to my watchlist
Technology Electronic Components

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
RAK
Ann: Rakon 2024 Annual Meeting Results 		28/08/24 0 58
28/08/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  58 
RAK
Ann: Rakon 2024 Annual Meeting Speeches 		28/08/24 0 42
28/08/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  42 
RAK
Ann: Rakon Annual Meeting 2024 Presentation 		28/08/24 0 72
28/08/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  72 
RAK
Ann: Rakon Releases FY25 Guidance 		28/08/24 0 95
28/08/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  95 
RAK
Ann: No continuous disclosure investigation 		27/08/24 0 83
27/08/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  83 
RAK
Ann: Rakon announces interim CFO and new executive position 		26/08/24 0 81
26/08/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  81 
RAK
Ann: Rakon launches ground-breaking semiconductor chip for space 		01/08/24 1 286
01/08/24 Last post  uphillnow Comments Created with Sketch.  1  Views Created with Sketch.  286 
RAK
Ann: Rakon Climate Statement FY2024 Announcement 		31/07/24 0 95
31/07/24 Last post  NZX News Comments Created with Sketch.  0  Views Created with Sketch.  95 

See All Discussions arrow Created with Sketch.

Featured News

NEWS Breakthrough FDA response clears path for OA phase 3 trial – major milestone achieved!
right-arrow Created with Sketch.
EBR $50M capital raise to scale EBR’s WiSE® System – FDA approval expected in 2025
right-arrow Created with Sketch.
NEWS $11.1M capital raise secured – CEO leads $1M push to fast-track alzheimers trial
right-arrow Created with Sketch.
(20min delay)
Last
66.0¢ 		Change
-0.020(2.94%) 		Mkt cap ! n/a
Open High Low Value Volume
68.0¢ 71.0¢ 66.0¢ $21.89K 32.62K

Buyers (Bids)

No. Vol. Price($)
0 7292 65.0¢
 

Sellers (Offers)

Price($) Vol. No.
71.0¢ 1187 0
Last trade - 12.59pm 20/09/2024 (20 minute delay) ?
RAK (NZSX) Chart

Top Stories

Westar wraps up field campaign at Mindoolah after divesting non-core assets ahead of 2025

Westar Resources (ASX:WSR) has wrapped up a field campaign on-site its Mindoolah Mining Centre project in WA.
Firetail executive changes set to propel development in Canada and Peru Firetail Resources Ltd has appointed former CEO Glenn Poole as managing director, while Brett Grosvenor has stepped into a non-executive role
Sandfire's latest drill run extends known polymetal mineralisation at the Sesmarias Prospect Sandfire Limited (ASX:SFR) has posted evidence of extended mineralisation at its Portugese Sesmarias Prospect.
Drilling shows continuous Cu mineralisation at Whundo for Greentech Greentech Metals Ltd has rolled out an extensive drilling program at the Whundo copper-zinc project 40 kilometres from Karratha
Catalina Resources kicks off aircore drilling at Laverton project on the hunt for gold, REEs Catalina Resources has confirmed its latest drill run has kicked off on-site its Laverton Project in Western Australia's Northern Goldfields.

Featured News

EBR $50M capital raise to scale EBR’s WiSE® System – FDA approval expected in 2025
right-arrow Created with Sketch.
NEWS Breakthrough FDA response clears path for OA phase 3 trial – major milestone achieved!
right-arrow Created with Sketch.
NEWS $11.1M capital raise secured – CEO leads $1M push to fast-track alzheimers trial
right-arrow Created with Sketch.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.